Stay updated with breaking news from Mathieu Charv. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lyon, France – 29 April 2024 – 6pm CET – Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological diseases, today publishes its results for the year ending 31...
On Wednesday morning, Theranexus shares posted one of the biggest rises on the Paris market in sustained volumes, following the announcement of promising results from a study in the juvenile form of...
Theranexus, a biopharmaceutical company specializing in rare neurological diseases, announces the appointment of Mathieu Charvériat as Chairman of the Board of Directors, in addition to his current...
Presentation at the International Congress on Neuronal Ceroid Lipofuscinoses NCL2023 Lyon, France – Austin, Texas, United States – 29 September 2023 – 7.30am – CET – Theranexus, a...
THERANEXUS ANNOUNCES FIRST HALF 2023 FINANCIAL RESULTS Lyon, France – 28 September 2023 – 6pm CEST – Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological...